메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
Gene therapy has offered potential promises for treatment of the diseases that have not been curable using the currently available therapeutic approaches. To develop a successful gene therapeutic medicine, two essential components of gene therapy should be considered thoroughly. One is to choose a therapeutic gene and the other is to select a safe and efficient gene delivery vehicle to introduce a therapeutic gene to the target tissue. The latter has been the major challenge to develop a more efficient gene therapeutic approach. Here we evaluated preclinical safety of adeno-associated virus serotype 2(AAV2)-mediated gene delivery vector containing the green fluorescent protein (GFP), recombinant AAV2-GFP (rAAV2-GFP) and also examined in vitro transduction efficiency of rAAV2-GFP. The rAAV vectors were infected in MKN74 cancer cells much higher (> 90%) than in HUVECs. The results of the single dose toxicity and the immunotoxicity evaluations of rAAV2-GFP showed no toxic effects as a therapeutic vector. However, the genotoxicity study revealed that the rAAV2-GFP vectors were inserted into the genome of testis, but not inserted into the genomes of other organs such as liver and ovary. The data of rAAV2-GFP vector distribution monitored by a confocal microscopy demonstrated that the vectors transduced most of the tested organs although the GFP expression directed by rAAV was quite weak. The GFP expression in the liver and kidney was slightly higher than that in the rest of the organs. The results from RT-PCR to quantitate the expressed GFP transcripts in the tested organs were largely consistent with those of GFP protein expression monitored by a confocal microscopy. Taken altogether, our present study demonstrated that no preclinical safety evaluations that we carried out revealed any adverse effects as a gene delivery vector and suggests that AAV2-mediated gene delivery system can be one of the safest gene therapy vectors.

목차

Materials and Methods
Results and Discussion
Acknowledgments
References

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

이 논문과 함께 이용한 논문

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-510-016362616